Chinese expert consensus statement on the clinical application of AFP/AFP‐L3%/DCP using GALAD and GALAD‐like algorithm in HCC - Huang, Chenjun; Xiao, Xiao; Zhou, Lin; Chen, Fuxiang; Wang, Jianyi; Hu, Xiaobo; Gao, Chunfang; Chen, Jie; Duan, Yong; Duan, Zhaohui; Fang, Meng; Gao, Zhiyuan; et al. (Journal of clinical laboratory analysis, 2023)
Keywords: Algorithms; alpha‐fetoprotein (AFP); alpha‐fetoprotein‐L3% (AFP‐L3%); Biomarkers; Cancer therapies; Cholangiocarcinoma; Clinical medicine; Clinical practice guidelines; Consensus; des‐gamma‐carboxyprothrombin (DCP); Diagnosis; Family medical history; gender‐age‐AFP‐L3%‐AFP‐DCP (GALAD) model; Hepatitis B; Hepatocellular carcinoma; hepatocellular carcinoma (HCC); Liver cancer; Liver cirrhosis; Liver diseases; Malignancy; Medical diagnosis; Medical screening; Mortality; Surveillance; Tumors; Ultrasonic imaging; Viral infections; China; gender-age-AFP-L3%-AFP-DCP (GALAD) model; hepatocellular carcinoma (HCC); alpha-fetoprotein (AFP); des-gamma-carboxyprothrombin (DCP); alpha-fetoprotein-L3% (AFP-L3%)